These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 17329029)

  • 1. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in immune-based therapies of renal cell carcinoma.
    Lam JS; Belldegrun AS; Figlin RA
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1081-96. PubMed ID: 15606335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma.
    Rini BI; Campbell SC; Rathmell WK
    Curr Opin Oncol; 2006 May; 18(3):289-96. PubMed ID: 16552243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma: basic biology and clinical behavior.
    Franklin JR; Figlin R; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: current status and future prospects.
    Drucker BJ
    Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and molecular markers for renal cell carcinoma.
    Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New trends in the diagnosis and treatment of renal cell carcinoma].
    Zisman A
    Harefuah; 2002 Aug; 141(8):713-7, 761. PubMed ID: 12222136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
    Al-Ali BM; Ress AL; Gerger A; Pichler M
    Anticancer Res; 2012 Sep; 32(9):3727-32. PubMed ID: 22993312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing natural history of renal cell carcinoma.
    Pantuck AJ; Zisman A; Belldegrun AS
    J Urol; 2001 Nov; 166(5):1611-23. PubMed ID: 11586189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic models and algorithms in renal cell carcinoma.
    Lane BR; Kattan MW
    Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma and proteomics.
    Sandim V; Pereira DA; Ornellas AA; Alves G
    Urol Int; 2010; 84(4):373-7. PubMed ID: 20224258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal cell carcinoma in Iceland].
    Thoroddsen A; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2007 Apr; 93(4):283-97. PubMed ID: 17460340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
    Belldegrun AS; Klatte T; Shuch B; LaRochelle JC; Miller DC; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Dekernion JB; Pantuck AJ
    Cancer; 2008 Nov; 113(9):2457-63. PubMed ID: 18823034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma in children and adolescents.
    Spreafico F; Collini P; Terenziani M; Marchianò A; Piva L
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1967-78. PubMed ID: 21110762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.
    Breda A; Konijeti R; Lam JS
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):847-62. PubMed ID: 17555395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.